Pantene's New Product Boosts Procter & Gamble Stock

Procter & Gamble's stock (ISIN US7427181091) was trading at USD 144.70 on the NYSE at 9:41 a.m. ET on October 5, 2026, following the launch of Pantene's new Cream to Mist leave-in spray. The product, co-created with trichologist Abbey Yung, adds a fresh innovation catalyst to the company's beauty segment, which is currently experiencing modest growth.

The launch comes as Procter & Gamble reports fiscal 2026 net sales of USD 87.0 billion, a 3 percent increase from the previous year. However, organic sales growth was only 1 percent, suggesting that pricing and currency adjustments played a larger role than volume expansion. Operating profit declined to USD 19.7 billion from USD 20.5 billion, while diluted EPS rose slightly to USD 6.62.

Analysts remain cautiously optimistic, with MarketBeat reporting a Moderate Buy consensus and an average 12-month price target of USD 161.55, an 11.6 percent upside from the current price. However, the latest quarterly results were mixed, with revenue slightly below estimates at USD 21.20 billion, up 1.5 percent year over year.

The next key checkpoint for Procter & Gamble will be its first-quarter fiscal 2027 earnings discussion on October 22, 2026. The report will test whether product innovations like the Cream to Mist can drive stronger organic growth. As of October 5, 2026, the stock was 13.5 percent below its 52-week high of USD 167.25, with a market capitalization of USD 344.0 billion.